(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DARETODREAM PROJECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DARETODREAM PROJECT

ST13

US500000097423768

Class

35, 36, 41, 42, 44, 45

Filing

97423768

Registration

7600110

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/02/2025

Trademark type

Word

Nice classes

35, 36, 41, 42, 44, 45

Filing date

05/23/2022

Registration date

12/10/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/10/2024

Last transaction

12/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

05/22/2022

First use in commerce

05/22/2022

Drawing code

4

Owner type

99

Owner location

WASHINGTON, DC

Examiner

KHAN,AHSEN M

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BLOOD CANCER UNITED , INC.
The Leukemia & Lymphoma Society, Inc.

Representatives

ANDREW D. PRICE VENABLE LLP

Technical classification

Nice Classes

Class 35Class 36Class 41Class 42Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy

Class 36

Accepting and administering monetary charitable contributions in the field of cancer; providing financial sponsoring for clinical trials in the field of cancer

Class 41

Providing patient education services services in the nature of classescoursesworkshops in the field of cancer

Class 42

Conducting clinical trials in the nature of medical research in the field of cancer; consulting services for othershelping others designplanimplementmanage clinical trials in the field of cancer

Class 44

Providing medical counseling and information about medical terms and clinical trials to patientsfamilieshealthcare providers in the field of cancerincluding helping childrenpatientscaregiversparents and physicians to identify appropriate clinical trials for children with cancer; providing information in the field of cancer treatment; providing nutritional consultations to patientsfamiliescaregivers in the field of cancer

Class 45

Providing personal support services for patients and families of patients with canceremotional counseling and emotional support in the field of cancer

Publications

History of USPTO decisions and trademark events.

38 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/01/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/10/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/20/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/20/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/23/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/23/2024

IUAF

USE AMENDMENT FILED

08/19/2024

EISU

TEAS STATEMENT OF USE RECEIVED

08/19/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/26/2023

PUBO

PUBLISHED FOR OPPOSITION

12/26/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/06/2023

EXPT

EXPARTE APPEAL TERMINATED

11/20/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/20/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

11/20/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/20/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

11/20/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/16/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/14/2023

EXPI

EX PARTE APPEAL-INSTITUTED

11/14/2023

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

11/14/2023

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

11/14/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/14/2023

GNFR

FINAL REFUSAL E-MAILED

08/14/2023

CNFR

FINAL REFUSAL WRITTEN

08/14/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/10/2023

ALIE

ASSIGNED TO LIE

07/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/08/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/08/2022

GNRT

NON-FINAL ACTION E-MAILED

12/08/2022

CNRT

NON-FINAL ACTION WRITTEN

12/08/2022

DOCK

ASSIGNED TO EXAMINER

12/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/26/2022

NWAP

NEW APPLICATION ENTERED

05/26/2022

Continuous trademark protection

Get notified about every new filing that threatens DARETODREAM PROJECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.